ArticleClinical medicine insights. Endocrinology and diabetes2024

Benefit-Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: Correspondence.

Hinpetch Daungsupawong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.